Use of three different supraglottic airway devices as a conduit for tracheal intubation in surgery: a randomised comparative study
Department of Anesthesiology and Intensive Care, University General Hospital of Patras, Rio, Greece
Second Department of Surgery, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
Department of General Surgery, University General Hospital of Patras, Rio, Greece
Department of Otolaryngology, University General Hospital of Patras, Rio, Greece
First Department of Otolaryngology, Hippokration General Hospital, National and Kapodistrian University of Athens, Greece
Department of Cardiothoracic and Vascular Surgery, Westpfalz Klinikum, Kaiserslautern, Germany
Introduction
Supraglottic airway devices (SADs) can serve as conduits for tracheal intubation (TI) during difficult airway management.
Aim
This study aims to assess three different SADs used for TI in patients undergoing elective surgery under general anaesthesia, comparing one first-generation SAD with two second-generation SADs.
Material and methods
This prospective, randomised clinical study included 193 adult patients (ASA I-II) who were randomly assigned to three groups. The first group underwent blind TI using the intubating LMA (Fastrach™), the second group via the I-gel®, and the third group through the LMA Protector™, with the latter two procedures guided by a flexible bronchoscope. The primary outcome measured was the time to successful tracheal intubation following placement of the SAD. Secondary outcomes included time from SAD introduction to ventilation, first pass success rates for both SAD and intubation, total procedure time and the oropharyngeal leak pressure.
Results
I-gel® had a longer time to TI than Fastrach™ (p < 0.001) and Protector™ (p = 0.03), and Protector™ was slower than Fastrach™ (p < 0.001). The time from SAD introduction to ventilation was longer with Fastrach™ and Protector™ compared to I-gel® (p < 0.001). Total procedure time was extended in the Protector™ group compared to both Fastrach™ and I-gel® (p < 0.001 for both), and in I-gel® compared to Fastrach™ (p < 0.001). TI success rates were comparable for I-gel® (95.4%) and Protector™ (96.9%), but lower for Fastrach™ (92.2%). Notably, oropharyngeal leak pressure was significantly higher with the Protector™ compared to the I-gel® (p < 0.001).
Conclusions
I-gel® and ProtectorTM produced similar outcomes as conduits for assisted intubation, both achieving high TI success rates. Fastrach™, however, was associated with a statistically significant reduction in unassisted intubation time. These results suggest that additional research in this area may be warranted.
Keywords
tracheal intubation, gastrointestinal surgery, Fastrach, I-gel, protector, supraglottic airway device
Coverage in
Integrated with

